Section Arrow
Quote
HRMY.NASDAQ
- Harmony Biosciences Holdings
Quotes are at least 15-min delayed:2024/06/25 02:00 EDT
Last
 30.1
-0.03 (-0.10%)
Day High 
32.38 
Prev. Close
30.13 
1-M High
30.57 
Volume 
514.42K 
Bid
30.1
Ask
30.1
Day Low
30.02 
Open
30.28 
1-M Low
28.57 
Market Cap 
1.71B 
Currency USD 
P/E 12.99 
%Yield 0 
10-SMA 29.56 
20-SMA 29.6 
50-SMA 29.84 
52-W High 39.265 
52-W Low 18.6112 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.32/1.45
Enterprise Value
1.89B
Balance Sheet
Book Value Per Share
9.08
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
582.02M
Operating Revenue Per Share
9.54
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.3662-0.0582-13.71%-- 
REVBRevelation Biosciences2.37+0.26+12.32%-- 
GLYCGlycoMimetics0.2648+0.0075+2.91%-- 
ALTAltimmune7.135+0.725+11.31%-- 
MBIOMustang Bio0.5703+0.015+2.70%-- 
Quotes are at least 15-min delayed：2024/06/25 02:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX(pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.